NuVasive was funding four medical research projects led by Dr. Taylor. The medical device company provided $16,821 for one project, while the three other projects were funded with an undisclosed amount. Dr. Taylor told the FPPC that he did not intend to keep the information a secret and did not mean to leave out information about his NuVasive income on his state-mandated statements of economic interest, according to the report.
Dr. Taylor tried to rectify the situation by discontinuing two projects. The FPPC fined Dr. Taylor $12,000.
Read the news report about Dr. William Taylor.
Read other coverage about NuVasive:
– NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
– NuVasive Settles Patent Dispute With Orthofix, Includes $2M Settlement
– NuVasive Reports 2Q Revenue Up 35.2%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
